NCT07936058
A Phase I Study to Evaluate the Food Effect on Ecnoglutide Tablet
StatusNot Yet Recruiting
PhasePhase 1
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Maximum concentration
Timeframe: From Day1 to Day42
Minimum concentration
Timeframe: From Day1 to Day42
Area under the curve from time 0 to infinity
Timeframe: From Day1 to Day42
Area under the curve from time 0 to 24h
Timeframe: From Day1 to Day42
Area under the curve from time 0 to last quantifiable time point
Timeframe: From Day1 to Day42
Time to reach maximum concentration
Timeframe: From Day1 to Day42
Secondary (2)
The incidence of adverse events
Anti-drug antibody
Arms and interventions
F1Experimental
Day 1 to Day 14: Fast overnight for at least 10 hours before each dose, and take the tablet with 240 mL of plain water. No food intake is allowed within 4h after dose administration.
F2Experimental
Day 1 to Day 13: take breakfast within 30min before each dose, and then take the tablet with 240 mL of plain water. No food intake is allowed within 4h after dose administration. Day 14: take breakfast with high fat and high calorie
T1Experimental
Day 1 to Day 14: fast after 30min of dosing
T2Experimental
Day 1 to Day 14: fast after 60min of dosing
Drugs: Dose 1, Dose 2
Sites
1 site in 1 country
- Zhejiang Provincial People's HospitalHangzhou, Zhejiang, China